Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness

Skeletal muscle wasting in the intensive care unit (ICU) has been associated with mortality, but it is unclear whether sarcopenia, defined by skeletal muscle mass and function, is useful for detailed risk stratification after ICU discharge. In this cohort study, 72 critically ill patients with an IC...

Full description

Bibliographic Details
Main Authors: Naoya Yanagi, Tomotaka Koike, Kentaro Kamiya, Nobuaki Hamazaki, Kohei Nozaki, Takafumi Ichikawa, Atsuhiko Matsunaga, Masayuki Kuroiwa, Masayasu Arai
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/8/2726
_version_ 1797522598552141824
author Naoya Yanagi
Tomotaka Koike
Kentaro Kamiya
Nobuaki Hamazaki
Kohei Nozaki
Takafumi Ichikawa
Atsuhiko Matsunaga
Masayuki Kuroiwa
Masayasu Arai
author_facet Naoya Yanagi
Tomotaka Koike
Kentaro Kamiya
Nobuaki Hamazaki
Kohei Nozaki
Takafumi Ichikawa
Atsuhiko Matsunaga
Masayuki Kuroiwa
Masayasu Arai
author_sort Naoya Yanagi
collection DOAJ
description Skeletal muscle wasting in the intensive care unit (ICU) has been associated with mortality, but it is unclear whether sarcopenia, defined by skeletal muscle mass and function, is useful for detailed risk stratification after ICU discharge. In this cohort study, 72 critically ill patients with an ICU stay of ≥48 h were identified. Skeletal muscle mass was assessed from the muscle thickness (MT) of the patients’ quadriceps using ultrasound images before ICU discharge. Skeletal muscle function was assessed from the patients’ muscle strength (MS) before ICU discharge according to the Medical Research Council sum score. A diagnosis of sarcopenia in the ICU was made in patients with low MT and low MS. The study endpoint was 1-year mortality. Sarcopenia in the ICU was diagnosed in 26/72 patients (36%). After adjusting for covariates in the Cox regression, sarcopenia in the ICU was significantly associated with 1-year mortality (hazard ratio 3.82; 95% confidence interval, 1.40–10.42). Sarcopenia in the ICU, defined by low skeletal muscle mass and function, was associated with 1-year mortality in survivors of critical illness. Skeletal muscle mass and function assessed at the bedside could be used to identify higher-risk patients in the ICU.
first_indexed 2024-03-10T08:30:44Z
format Article
id doaj.art-ea2bb26a4d904b00819574eaca05f214
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T08:30:44Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-ea2bb26a4d904b00819574eaca05f2142023-11-22T09:05:11ZengMDPI AGNutrients2072-66432021-08-01138272610.3390/nu13082726Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical IllnessNaoya Yanagi0Tomotaka Koike1Kentaro Kamiya2Nobuaki Hamazaki3Kohei Nozaki4Takafumi Ichikawa5Atsuhiko Matsunaga6Masayuki Kuroiwa7Masayasu Arai8Department of Rehabilitation Sciences, Graduate School of Medical Sciences, Kitasato University, Sagamihara 252-0373, JapanDepartment of Intensive Care Center, Kitasato University Hospital, Sagamihara 252-0329, JapanDepartment of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara 252-0373, JapanDepartment of Rehabilitation, Kitasato University Hospital, Sagamihara 252-0329, JapanDepartment of Rehabilitation, Kitasato University Hospital, Sagamihara 252-0329, JapanDepartment of Rehabilitation, Kitasato University Hospital, Sagamihara 252-0329, JapanDepartment of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara 252-0373, JapanDepartment of Anesthesiology, School of Medicine, Kitasato University, Sagamihara 252-0373, JapanDivision of Intensive Care Medicine, Department of Research and Development Center for New Medical Frontiers, School of Medicine, Kitasato University, Sagamihara 252-0373, JapanSkeletal muscle wasting in the intensive care unit (ICU) has been associated with mortality, but it is unclear whether sarcopenia, defined by skeletal muscle mass and function, is useful for detailed risk stratification after ICU discharge. In this cohort study, 72 critically ill patients with an ICU stay of ≥48 h were identified. Skeletal muscle mass was assessed from the muscle thickness (MT) of the patients’ quadriceps using ultrasound images before ICU discharge. Skeletal muscle function was assessed from the patients’ muscle strength (MS) before ICU discharge according to the Medical Research Council sum score. A diagnosis of sarcopenia in the ICU was made in patients with low MT and low MS. The study endpoint was 1-year mortality. Sarcopenia in the ICU was diagnosed in 26/72 patients (36%). After adjusting for covariates in the Cox regression, sarcopenia in the ICU was significantly associated with 1-year mortality (hazard ratio 3.82; 95% confidence interval, 1.40–10.42). Sarcopenia in the ICU, defined by low skeletal muscle mass and function, was associated with 1-year mortality in survivors of critical illness. Skeletal muscle mass and function assessed at the bedside could be used to identify higher-risk patients in the ICU.https://www.mdpi.com/2072-6643/13/8/2726critical illnesssarcopeniaskeletal muscle massskeletal muscle functionultrasound
spellingShingle Naoya Yanagi
Tomotaka Koike
Kentaro Kamiya
Nobuaki Hamazaki
Kohei Nozaki
Takafumi Ichikawa
Atsuhiko Matsunaga
Masayuki Kuroiwa
Masayasu Arai
Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness
Nutrients
critical illness
sarcopenia
skeletal muscle mass
skeletal muscle function
ultrasound
title Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness
title_full Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness
title_fullStr Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness
title_full_unstemmed Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness
title_short Assessment of Sarcopenia in the Intensive Care Unit and 1-Year Mortality in Survivors of Critical Illness
title_sort assessment of sarcopenia in the intensive care unit and 1 year mortality in survivors of critical illness
topic critical illness
sarcopenia
skeletal muscle mass
skeletal muscle function
ultrasound
url https://www.mdpi.com/2072-6643/13/8/2726
work_keys_str_mv AT naoyayanagi assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness
AT tomotakakoike assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness
AT kentarokamiya assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness
AT nobuakihamazaki assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness
AT koheinozaki assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness
AT takafumiichikawa assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness
AT atsuhikomatsunaga assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness
AT masayukikuroiwa assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness
AT masayasuarai assessmentofsarcopeniaintheintensivecareunitand1yearmortalityinsurvivorsofcriticalillness